New treatment for sickle cell
Two brothers have been cured of their sickle cell disease at the University of Illinois Hospital & Health Sciences System using a relatively uncommon type of stem cell transplant that is performed without chemotherapy. Their transplants were possible thanks to a third brother who was a match for both, against long odds.
»Story: New treatment for sickle cell brings hope, cure
Appointments
Bellur Prabhakar, PhD
Professor Bellur Prabhakar has agreed to join the Dean’s Office, effective March 1, 2013. More
Greetings from the College of Medicine
As we work together to educate the next generation of medical doctors and researchers, and as we continue to discover better ways to care for our community, I wish you and your family the very best for 2012. The College of Medicine is making important advances in medical education and clinically-relevant research; we look forward to future success as we continue to provide world-class education, medical care, and research.
Dimitri T. Azar, MD, MBA
Dean, University of Illinois College of Medicine
First in Chicago to Offer New Treatment
Vitreomacular adhesion, or VMA, is a disease in which the vitreous, the clear jelly-like substance filling the center of the eye, shrinks with age and pulls the retina inward. Vision becomes distorted, and if the retina tears, serious vision loss and even blindness can result. UI Health is the first center in Chicago to offer a new, nonsurgical treatment for the disease, which affects half a million people in the U.S .
»Follow this link for full story.